Imatinib Mesylate from China
Imatinib mesylate is a tyrosine kinase inhibitor used primarily as an anticancer drug for treating chronic myeloid leukemia. This aromatic heterocyclic compound with nitrogen hetero-atoms falls under HTS 2933.99.75.00 as it is classified as a drug containing a modified aromatic nitrogen heterocyclic structure.
Duty Rate — China → United States
6.5%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Obtain FDA approval and Drug Master File (DMF) prior to import as it's a pharmaceutical substance
• Ensure Certificate of Analysis (CoA) verifies purity >99% and compliance with USP standards
• Avoid misclassification as a research chemical; declare as bulk drug substance for medicinal use